Results 81 to 90 of about 76,979 (321)

Vaccination in Kidney Transplant Candidates

Transplantation Direct, 2023
Background:. Kidney transplant (KT) candidates have historically low immunization rates against recommended vaccines. A retrospective single-center study of contemporary KT candidates was conducted to assess vaccination rates and vaccine uptake. Methods:.
Kiran Gajurel, MD, Tue Ngo, MD, MPH, Robert T. Fairman, PhD, MPH, Lewis H. McCurdy, MD   +3 more
doaj   +1 more source

Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. [PDF]

, 2008
BACKGROUND: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invasive disease in Gambian children METHODS: One hundred and thirty-two S. pneumoniae isolates were recovered from children aged 2-29 months during the course
Adegbola, Richard A, Antonio, Martin, Awine, Tim, Biney, Ekow, Cutts, Felicity, Dada-Adegbola, Hannah, Enwere, Godwin, Greenwood, Brian M, O'Callaghan, John, Okoko, Brown, Oluwalana, Claire, Pfluger, Valentin, Pluschke, Gerd, Vaughan, Adeola, Zaman, Syed Ma   +14 more
core   +2 more sources

The Nurse Practitioner's Immuniser Role in Primary Healthcare: A Scoping Review

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim(s) This scoping review aimed to explore and identify literature about the scope of practice for nurse practitioners working as immunisers in primary healthcare. Design The review was conducted according to the JBI scoping review framework.
Christine Schoenfisch, Kate Kauter, Leah East   +2 more
wiley   +1 more source

Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023

Emerging Infectious Diseases
Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease.
Terry Komo, Patrick K. Munywoki, Maria da Gloria Carvalho, Joshua Auko, Alice Ouma, Allan Audi, George O. Agogo, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Newton Wamola, Mike Osita, Clayton Onyango, Naomi Lucchi, Peninah Munyua, Amy Herman-Roloff, Shanda Larson, Sopio Chochua, Fabiana C. Pimenta, Godfrey Bigogo, Jennifer R. Verani   +20 more
doaj   +1 more source

Understanding hesitancy with revealed preferences across COVID-19 vaccine types [PDF]

arXiv, 2021
Many countries have secured larger quantities of COVID-19 vaccines than their populace is willing to take. This abundance and variety of vaccines created a historical moment to understand vaccine hesitancy better. Never before were more types of vaccines available for an illness and the intensity of vaccine-related public discourse is unprecedented ...
arxiv  

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations

Clinical Infectious Diseases, 2017
Background Pneumococccal conjugated pneumococcal vaccine (PCV10) and pneumococcal conjugate vaccine 13 (PCV13), are used in childhood immunization programs worldwide, but direct comparisons of impacts against invasive pneumococcal disease (IPD) in ...
P. Nauclér, I. Galanis, E. Morfeldt, J. Darenberg, Å. Örtqvist, B. Henriques-Normark   +5 more
semanticscholar   +1 more source

Challenges to estimating vaccine impact using hospitalization data. [PDF]

, 2017
Because the real-world impact of new vaccines cannot be known before they are implemented in national programs, post-implementation studies at the population level are critical.
Bruhn, Christian AW, Kürüm, Esra, Lustig, Roger, Schuck-Paim, Cynthia, Simonsen, Lone, Taylor, Robert J, Weinberger, Daniel M   +6 more
core   +3 more sources

Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy

Transplant Infectious Disease, EarlyView.
ABSTRACT Vaccine adjuvants are essential for enhancing immune responses to vaccines, particularly in immunocompromised populations who typically demonstrate suboptimal responses to standard vaccination. This narrative review evaluates the safety and efficacy of approved and candidate adjuvants in immunocompromised hosts, with emphasis on solid organ ...
Haya Hayek, Lana Hasan, Justin Z. Amarin, Yasmeen Z. Qwaider, Olla Hamdan, Wanderson Rezende, Kevin C. Dee, James D. Chappell, Natasha B. Halasa   +8 more
wiley   +1 more source

Analysis of COVID-19 in India using vaccine epidemic model incorporating vaccine effectiveness and herd immunity [PDF]

arXiv, 2022
COVID-19 will be a continuous threat to human population despite having a few vaccines at hand until we reach the endemic state through natural herd immunity and total immunization through universal vaccination. However, the vaccine acts as a practical tool for reducing the massive public health problem and the emerging economic consequences that the ...
arxiv  

Asymmetric participation of defenders and critics of vaccines to debates on French-speaking Twitter [PDF]

Sci Rep 10, 6599 (2020). https://doi.org/10.1038/s41598-020-62880-5, 2019
For more than a decade, doubt about vaccines has become an increasingly important global issue. Polarization of opinions on this matter, especially through social media, has been repeatedly observed, but details about the balance of forces are left unclear.
arxiv   +1 more source